Article Text

other Versions

PDF
A new 24 h ELISA culture based method for Helicobacter pylori chemosusceptibility
  1. Federico Perna,
  2. Dino Vaira
  1. Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy
  1. Correspondence to Professor Dino Vaira, Department of Internal Medicine and Gastroenterology, S. Orsola Hospital, Via Massarenti 9, 40138 Bologna, Italy; berardino.vaira{at}unibo.it

Abstract

Background Clarithromycin (CH) and metronidazole (MZ) are routinely used in Helicobacter pylori treatment regimes. Recently, treatment with these antibiotics has been reported to fail in >30% of patients due to increasing resistance. The common chemosusceptibility methods are cumbersome and take up to 14 days. Chemosusceptibility of H pylori is therefore rarely checked.

Aim To develop a rapid susceptibility test (RST) for H pylori.

Methods Preliminary experiments were performed to find a broth medium able to support the growth of H pylori in 20 h and a reliable detection method to quickly detect the amount of H pylori grown in the media. A mixture of different components was the best broth medium; ELISA was chosen as the detection technique. Performance of the new RST was compared to a gold standard (break point agar dilution method). 200 consecutive patients were tested for H pylori infection and chemosusceptibility to CH and MZ by the gold standard and RST.

Results 111 patients were infected with H pylori. 105 of these were positive by both RST and the gold standard culture method; 75/105 and 68/105 strains were susceptible to CH and MZ, respectively. RST misdiagnosed 2 strains of CH and 10 strains of MZ.

Conclusions A new simple and rapid chemosusceptibility test for H pylori has been validated, which is simple to perform and reduces the procedure time from 6–14 days to 24 h.

  • Antibiotics
  • drug resistance
  • helicobacter pylori
  • helicobacter pylori - assessment
  • helicobacter pylori - susceptibility

Statistics from Altmetric.com

Footnotes

  • This paper refers to the patent pending application ‘A chemosusceptibility rapid test for Helicobacter pylori’ PCT/IT2007/000270; applicant: Alma Mater Studiorum, University of Bologna. For more detailed information about the invention, please refer to the Knowledge Transfer Office at: +390512099439; e-mail: business.team{at}unibo.it; website: http://www.unibo.it/services for companies.

  • Funding This work was financially partially supported by the University of Bologna.

  • Competing interests None.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.